$ATNM
Actinium Pharmaceuticals, Inc
XASE•Health Care•Pharmaceutical Preparations
$1.07
▼-3.60%-$0.040
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateActinium Pharmaceuticals, Inc
XASE•Health Care•Pharmaceutical Preparations
Why is ATNM down today? It is at $1.07 (-3.60%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ATNM spikes, and full due diligence on ATNM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ATNM 7 times in the last 30 days. Create a free account to track $ATNM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ATNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ATNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Chell Jeffrey W. Director | Acquired (grant/award) | +62K 0.2% of company | n/a | 62K | n/a | Sep 2, 26 |
Steinhart Richard I Director | Acquired (grant/award) | +63K 0.2% of company | added 100% | 63K | n/a | Sep 2, 26 |
Shetty Ajit Director | Acquired (grant/award) | +62K 0.2% of company | added 100% | 62K | n/a | Sep 2, 26 |
Seth Sandesh Officer | Acquired (grant/award) | +1.78M 5.7% of company | added 100% | 1.97M | n/a | Sep 2, 26 |
Nicholson, C. David Director | Acquired (grant/award) | +63K 0.2% of company | added 100% | 63K | n/a | Sep 2, 26 |
Almenoff June Sherie Director | Acquired (grant/award) | +18K 0.06% of company | n/a | 18K | n/a | Sep 2, 26 |
Seth Sandesh Officer | Sold (automatic/other) | -121K 0.4% of company | sold 40% | 184K | $207K at $1.71 | Aug 18, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ATNM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ATNM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ATNM last traded at $1.07, down 3.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Actinium Pharmaceuticals, Inc (ATNM) is next expected to report earnings on Friday, November 13, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ATNM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ATNM 7 times in the last 30 days.
ATNM (Actinium Pharmaceuticals, Inc) trades on XASE, with a market cap of about $34M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ATNM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ATNM discussion
Sign in to ask a question or join the discussion.